2011 ASH Program Book - American Society of Hypertension

More documents

Recommendations

Info

MAY 22 Posters Sunday Morning PO-170: PO-171: PO-172: PO-173: PO-174: PO-175: PO-176: PO-177: PO-178: Combination Aliskiren/Amlodipine with and without Diuretic in Minorities with Hypertension and Metabolic Syndrome or Diabetes Keith C. Ferdinand†, 1 Richard Weitzman, 2 Das Purkayastha, 2 Kanaka Sridharan, 2 Edgar A. Jaimes. 3 1 Emory University, Atlanta, GA, US; 2 Novartis Pharmaceuticals Corp, East Hanover, NJ, US; 3 Univ of Alabama at Birmingham, Birmingham, AL, US. Efficacy and Safety of Olmesartan Medoxomil Versus Losartan Potassium in Subjects with Stage 1 or 2 Hypertension John M. Flack†, 1 Alan Graff, 2 Wei Li, 3 Kathleen J. Chavanu, 3 Robert Dubiel. 3 1 Wayne State University School of Medicine, US; 2 Private Practice, US; 3 Daiichi Sankyo, Inc., US. Decreasing Sleep-Time Blood Pressure Determined by Ambulatory Monitoring Reduces Cardiovascular Risk in Resistant Hypertension Ramon C. Hermida, 1 Diana E. Ayala, 1 Artemio Mojon, 1 Luisa Chayan, 2 Maria J. Dominguez, 3 Maria J. Fontao, 1 Ignacio Alonso, 1 Jose R. Fernandez. 1 1 University of Vigo, Vigo, ES; 2 Urgencias Sanitarias 061 Galicia, Santiago, ES; 3 Policlinica La Rosaleda, Santiago, ES. Influence of Circadian Time of Blood Pressure- Lowering Treatment on Cardiovascular Risk in Resistant Hypertension Ramon C. Hermida, Diana E. Ayala, Artemio Mojon, Jose R. Fernandez. University of Vigo, Vigo, ES. Administration-Time Differential Benefit on Cardiovascular Risk Reduction of the Various Classes of Hypertension Medications Ramon C. Hermida, Diana E. Ayala, Artemio Mojon, Jose R. Fernandez. University of Vigo, Vigo, ES. Influence of Number of Hypertension Medications and Circadian Time of Treatment on Cardiovascular Morbidity and Mortality Ramon C. Hermida, Diana E. Ayala, Artemio Mojon, Jose R. Fernandez. University of Vigo, Vigo, ES. Doppler Measurement of Ankle Brachial Index is Still the Standard in Screening of Peripheral Arterial Disease Laura Rantamaula, Juha Varis, Ilkka M. Kantola. Turku University Hospital, Turku, FI. Comparative Effects of Carvedilol and Valsartan on Cardiac Workload Shaila Karan†, Sirisha Srikakarlapudi, Minesh Rajpal, Peter J. Osmond, Joseph L. Izzo, Jr. SUNY at Buffalo, Buffalo, NY, US. Olmesartan + CCB vs Olmesartan + Diuretic as Combination Therapy for Elderly Hypertensive Patients Johji Kato, Naoto Yokota, Toshihiro Kita, Tanenao Eto, Kazuo Kitamura. University of Miyazaki, Miyazaki City, Miyazaki, JP. 114
Sunday Morning MAY 22 Posters PO-179: PO-180: PO-181: PO-182: PO-183: PO-184: Efficacy and Safety of Olmesartan Medoxomil Versus Losartan Potassium in Antihypertensive Naïve/Non-Naïve Subjects Henry A. Punzi†, 1 Andrew Lewin, 2 Wei Li, 3 Kathleen J. Chavanu, 3 Robert Dubiel. 3 1 Trinity Hypertension and Metabolic Research Institute, US; 2 National Research Institute, US; 3 Daiichi Sankyo, Inc., US. Computer-Mediated System, WHEELS-I, Provides Evidence of Feasibility for Momentary Assessment of DASH Diet Adherence over 8 Weeks Margaret Scisney‐Matlock, 1 Susan Steigerwalt, 2 Kenneth Jamerson, 1 Amanda Sen, 1 Susan Pressler, 1 Elizabeth Brough. 1 1 University of Michigan, Ann Arbor, MI, US; 2 St. John Health System, Detroit, US. Carvedilol Reduces Aortic Wave Reflection and Improves Left Ventricular/Vascular Coupling Compared to Atenolol: The CENTRAL Study Niren K. Shah†, 1 Benjamin J. Epstein, 1,2 Wilmer W. Nichols, 2 Steven M. Smith, 2 Julie A. Johnson. 2 1 East Coast Institute for Research, Jacksonville, FL, US; 2 University of Florida, Gainesville, FL, US. Fixed-Dose Combination of Azilsartan Medoxomil/ CLD Provides Superior BP Reduction to Monotherapies in Stage 2 HTN D. Sica†, 1 G. L. Bakris, 2 W. B. White, 3 M. A. Weber, 4 W. C. Cushman, 5 A. Roberts, 6 C. Cao, 6 S. Kupfer. 6 1 VA Commonwealth U Health System, Richmond, VA, US; 2 U of Chicago Pritzker School of Medicine, Chicago, IL, US; 3 U of CT School of Medicine, Farmington, CT, US; 4 New York, NY, US; 5 U of TN College of Medicine, Memphis, TN, US; 6 Takeda Global Research & Development, Deerfield, IL, US. Efficacy of an Amlodipine/Olmesartan Medoxomil Algorithm in Patients Uncontrolled on Prior ACE Inhibitor Monotherapy Matthew R. Weir†, 1 Alan Graff, 2 Ali Shojaee, 3 William F. Waverczak, 3 Jen‐Fue Maa. 3 1 University of Maryland School of Medicine, US; 2 Private Practice, US; 3 Daiichi Sankyo, Inc., US. Pilot Randomized Controlled Trial of Intensive Blood Pressure Control in Hemodialysis Dialysis Patients: The BID Trial Philip Zager, 1 Dana Miskulin, 2 Jennifer Gassman. 3 1 University of New Mexico Health Sciences Center, Albuquerque, NM, US; 2 Tufts Medical Center, Boston, MA, US; 3 Cleveland Clinic Research Foundation, Cleveland, OH, US. Coronary Artery Disease PO-185: Blood Pressure and Heart Related Quality of Life One Year Post Myocardial Infarction Antonios Ioannidis, Dimitrios Tsounis. Hellenic Open University, GR. 115
Page 1 and 2:
American Society of Hypertension, I
Page 3:
Visit booth #1100 to find out more
Page 6 and 7:
Past Presidents of the American Soc
Page 8 and 9:
Program Color Key The pages of this
Page 10 and 11:
Letter continued Following the Awar
Page 12 and 13:
General Information continued Discl
Page 14 and 15:
General Information continued ASH S
Page 16 and 17:
General Information continued ASH P
Page 18 and 19:
2011 ASH Corporate Members Boehring
Page 20 and 21:
ASH Leadership 2010-2011 Board of D
Page 22 and 23:
Special Lecture Monday, May 23, 201
Page 24 and 25:
Young Scholar Award* Monday, May 23
Page 26 and 27:
Special Lecture Monday, May 23, 201
Page 28 and 29:
2011 Abstract Reviewers Lawrence J.
Page 30 and 31:
More than half of hypertensive pati
Page 32 and 33:
Poster Category Presentation Poster
Page 34 and 35:
2011 ASH Faculty Rajiv Agarwal, MD
Page 36 and 37:
2011 ASH Faculty continued David L.
Page 38 and 39:
American Society of Hypertension, I
Page 40 and 41:
Program Color Key The pages of this
Page 42 and 43:
MAY 21 Saturday Morning Hypertensio
Page 44 and 45:
MAY 21 Sessions Saturday Afternoon
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
MAY 21 Posters Saturday Evening Pos
Page 52 and 53:
MAY 22 Sunday morning Sessions cont
Page 54 and 55:
MAY 22 Sessions Sunday Morning 9:00
Page 56 and 57:
MAY 22 Sessions Sunday Morning 9:00
Page 58 and 59:
MAY 22 Debates Sunday Morning 11:00
Page 60 and 61:
MAY 22 Plenary Session I Sunday Aft
Page 62 and 63:
MAY 22 Special Sessions Sunday Afte
Page 64 and 65:
MAY 22 Sessions Sunday Afternoon 3:
Page 66 and 67: MAY 23 Satellite Symposium 6:00 AM
Page 68 and 69: MAY 23 Sessions Monday morning 8:00
Page 78 and 79: MAY 23 Plenary Session II Monday Af
Page 80 and 81: MAY 24 Sessions Tuesday Morning 8:1
Page 82 and 83: MAY 24 Sessions Tuesday Morning 10:
Page 84 and 85: MAY 24 Sessions Tuesday Morning 10:
Page 87 and 88: 2011 American Society of Hypertensi
Page 89 and 90: Saturday Afternoon MAY 21 Posters 4
Page 91 and 92: Saturday Afternoon MAY 21 Posters P
Page 93 and 94: Saturday Afternoon MAY 21 Posters E
Page 99 and 100: Saturday Afternoon MAY 21 Posters I
Page 107 and 108: Sunday Morning MAY 22 Posters 10:00
Page 109 and 110: Sunday Morning MAY 22 Posters 10:00
Page 111 and 112: Sunday Morning MAY 22 Posters PO-13
Page 115: Sunday Morning MAY 22 Posters PO-16
Page 127 and 128: Monday Morning Afternoon MAY 21 23
Page 147 and 148: Faculty Disclosure Listing Rajiv Ag
Page 149 and 150: Faculty Disclosure Listing continue
Page 157 and 158: ASH Hypertension Resource Pavilion
Page 159 and 160: 2011 ASH Innovations Theater Rhinel
Page 161 and 162: 2011 ASH Exhibitors continued A & D
Page 163 and 164: 2011 ASH Exhibitors continued David
Page 165 and 166: 2011 ASH Exhibitors continued Inter
Page 167 and 168:
2011 ASH Exhibitors continued Novar
Page 169 and 170:
2011 ASH Exhibitors continued Wiley
Page 171 and 172:
Author Index Berezina, Aelita V., 8
Page 173 and 174:
Author Index Eguchi, Kazuo, 110, 13
Page 175 and 176:
Author Index Ikeda, Yasuhiro, 116 I
Page 177 and 178:
Author Index Makani, Harikrishna, 1
Page 179 and 180:
Author Index Rabelink, Ton J., 93 R
Page 181 and 182:
Author Index Tatsis, I., 92, 124 Ta
Page 183 and 184:
Hilton New York Floor Plans Second
Page 185 and 186:
Hilton New York Floor Plans Fourth
Page 187 and 188:
Tekamlo (aliskiren and amlodipine)
Page 189 and 190:
25% (systolic) and 27% (diastolic)
Page 191 and 192:
Two cases of angioedema with respir
Page 193 and 194:
amlodipine and sildenafil were used
Page 195 and 196:
Amlodipine besylate Single oral dos
show all

2011 ASH Program Book - American Society of Hypertension

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?